Skip to main content
Article thumbnail
Location of Repository

Why are tumour blood vessels abnormal and why is it important to know?

By J A Nagy, S-H Chang, A M Dvorak and H F Dvorak

Abstract

Tumour blood vessels differ from their normal counterparts for reasons that have received little attention. We report here that they are of at least six distinct types, we describe how each forms, and, looking forward, encourage the targeting of tumour vessel subsets that have lost their vascular endothelial growth factor-A (VEGF-A) dependency and so are likely unresponsive to anti-VEGF-A therapies

Topics: Minireview
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2661770
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2003). Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.
    2. (2007). Biol 59: 100–115 Dvorak H
    3. (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.
    4. (2002). Cytochem 50: 71–79
    5. (2002). Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.